Cargando…

Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies

In order to quantify the association between use of statins and the risk of all hematological malignancies and of subtypes, we performed a meta-analysis of observational studies. We achieved a MEDLINE/EMBASE comprehensive search for studies published up to August 2014 investigating the association b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pradelli, Danitza, Soranna, Davide, Zambon, Antonella, Catapano, Alberico, Mancia, Giuseppe, La Vecchia, Carlo, Corrao, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430269/ https://www.ncbi.nlm.nih.gov/pubmed/25809667 http://dx.doi.org/10.1002/cam4.411

Ejemplares similares

Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries
por: Pizzato, Margherita, et al.
Publicado: (2022)

Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy
por: Hultcrantz, Malin, et al.
Publicado: (2015)

Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
por: Schonfeld, Sara J., et al.
Publicado: (2016)

Subtype‐specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002‐2012
por: Ko, Bor‐Sheng, et al.
Publicado: (2018)

Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies
por: Ducros, Elodie, et al.
Publicado: (2012)

Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population‐based study
por: Mo, Xiaofei, et al.
Publicado: (2021)

An analysis of the effect of statins on the risk of Non‐Hodgkin's Lymphoma in the Women’s Health Initiative cohort
por: Desai, Pinkal, et al.
Publicado: (2018)

Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta‐analysis
por: Li, Yue, et al.
Publicado: (2019)

Incidence and survival of hematological cancers among adults ages ≥75 years
por: Krok‐Schoen, Jessica L., et al.
Publicado: (2018)

Updated mortality study of a cohort of asbestos textile workers
por: Pira, Enrico, et al.
Publicado: (2016)

Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study
por: Wang, Kai, et al.
Publicado: (2019)

Racial difference in histologic subtype of renal cell carcinoma
por: Olshan, Andrew F, et al.
Publicado: (2013)

Relationship of established risk factors with breast cancer subtypes
por: McCarthy, Anne Marie, et al.
Publicado: (2021)

The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case‐control study in a Korean nationwide cohort
por: Choi, Jin Ho, et al.
Publicado: (2019)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
por: Seo, Seung In, et al.
Publicado: (2021)

Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012
por: Licaj, Idlir, et al.
Publicado: (2016)

Comparison of breast cancer risk factors among molecular subtypes: A case‐only study
por: Zhang, Liwen, et al.
Publicado: (2019)

Clinical and epidemiologic factors associated with breast cancer and its subtypes among Northeast Chinese women
por: Ye, Dong‐Man, et al.
Publicado: (2019)

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
por: Ma, Mingjun, et al.
Publicado: (2022)

Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee
por: Vidal, Gregory, et al.
Publicado: (2017)

Racial/ethnic disparities in renal cell carcinoma: Increased risk of early‐onset and variation in histologic subtypes
por: Batai, Ken, et al.
Publicado: (2019)

Hormone factors play a favorable role in female head and neck cancer risk
por: Hashim, Dana, et al.
Publicado: (2017)

Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL)
por: Padhye, Bhavna, et al.
Publicado: (2016)

The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation‐wide cancer registry‐based study from Taiwan
por: Chang, Jeffrey S., et al.
Publicado: (2018)

Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China
por: Yin, Xuejun, et al.
Publicado: (2019)

Mortality of lung cancer as a second primary malignancy: A population‐based cohort study
por: Deng, Lei, et al.
Publicado: (2019)

Body composition and risk of major gynecologic malignancies: Results from the UK Biobank prospective cohort
por: Yun, Peng, et al.
Publicado: (2021)

The association of cancer‐related fatigue with all‐cause mortality of colorectal and endometrial cancer survivors: Results from the population‐based PROFILES registry
por: Adam, Salome, et al.
Publicado: (2019)

An integrative histopathologic clustering model based on immuno‐matrix elements to predict the risk of death in malignant mesothelioma
por: Balancin, Marcelo Luiz, et al.
Publicado: (2020)

Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
por: Mitani, Seiichiro, et al.
Publicado: (2019)

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Bao, Shengnan, et al.
Publicado: (2021)

Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide
por: Rollison, Dana E., et al.
Publicado: (2016)

Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification
por: Muto, Reiji, et al.
Publicado: (2018)

DNA aneuploidy with image cytometry for detecting dysplasia and carcinoma in oral potentially malignant disorders: A prospective diagnostic study
por: Li, Chenxi, et al.
Publicado: (2020)

Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study
por: Sun, Zimin, et al.
Publicado: (2018)

Assessment of different mathematical models for diffusion‐weighted imaging as quantitative biomarkers for differentiating benign from malignant solid hepatic lesions
por: Hu, Yao, et al.
Publicado: (2018)

Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor
por: Li, Xiao‐Xiao, et al.
Publicado: (2018)

Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population‐based analysis
por: Lai, Yen‐Ling, et al.
Publicado: (2021)

Statin tolerability: In defence of placebo-controlled trials
por: Tobert, Jonathan A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rr8c7s5nu4ktsfn470be8lp6os